Update: 12.03.2024
Last week: 9 week 2024 (26.02.2024 - 03.03.2024)
Last full month: February 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 734 | 15.2% | 11.0% | -0.5 | 17 407 054 | 14.1% | 9.4% | -0.7 | 20.9% |
| MoM | 29 171 | 8.3% | 11.0% | -0.1 | 65 772 614 | 9.3% | 9.5% | -0.1 | 9.6% |
| YTD | 59 434 | 29.5% | 11.1% | 2.4 | 133 432 644 | 62.4% | 9.6% | 2.3 | 1.2% |
| MAT | 354 373 | 34.9% | 9.5% | 1.8 | 708 092 095 | 46.7% | 8.1% | 1.5 | 9.0% |
| BRAINMAX | |||||||||
| WoW | 1 112 | 23.6% | 100.0% | 0 | 4 172 720 | 28.6% | 100.0% | 0 | 23.6% |
| MoM | 3 949 | -7.8% | 100.0% | 0 | 14 394 547 | -5.2% | 100.0% | 0 | -7.8% |
| YTD | 8 717 | 86.4% | 100.0% | 0 | 31 397 995 | 98.6% | 100.0% | 0 | 86.4% |
| MAT | 50 691 | 241.0% | 100.0% | NA | 176 587 736 | 263.5% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 18 079 | 20.8% | 46.1% | 3.7 | 58 292 020 | 23.7% | 39.1% | 4.7 | 11.0% |
| MoM | 68 306 | 1.9% | 43.8% | 0.3 | 217 517 575 | -1.1% | 35.9% | -0.2 | 1.2% |
| YTD | 143 094 | 6.3% | 43.8% | 2.5 | 462 617 322 | 14.3% | 36.2% | -0.9 | 0.1% |
| MAT | 877 478 | 23.0% | 45.3% | 2.6 | 2 749 736 439 | 31.8% | 39.4% | 2.2 | 16.0% |
| MIGRENIUM | |||||||||
| WoW | 12 244 | 5.5% | 0.6% | 0 | 3 581 724 | 7.8% | 0.7% | 0 | 4.0% |
| MoM | 53 054 | 6.6% | 0.6% | 0.1 | 15 088 199 | 15.2% | 0.7% | 0.1 | -6.1% |
| YTD | 108 106 | 1.7% | 0.5% | -0.1 | 29 726 573 | 55.1% | 0.6% | 0.1 | 25.4% |
| MAT | 643 348 | 9.5% | 0.6% | 0 | 133 220 302 | 26.4% | 0.5% | 0 | 12.1% |
| MODELAX-N | |||||||||
| WoW | 35 540 | 17.1% | 25.4% | 2.3 | 14 725 034 | 17.6% | 15.9% | 1.6 | 6.4% |
| MoM | 129 731 | 8.5% | 23.0% | 2.9 | 53 054 568 | 12.2% | 14.2% | 2.2 | -5.0% |
| YTD | 264 637 | 61.2% | 21.7% | 4.9 | 106 675 534 | 101.9% | 13.2% | 3.4 | 25.2% |
| MAT | 1 268 406 | 141.3% | 19.5% | 9.7 | 436 640 808 | 149.1% | 11.0% | 5.5 | 21.2% |
| REDUXIN | |||||||||
| WoW | 12 257 | 4.9% | 31.3% | -1.8 | 63 619 964 | -0.4% | 42.6% | -4 | 11.0% |
| MoM | 51 307 | -2.3% | 32.9% | -1.2 | 277 156 731 | -2.7% | 45.7% | -1 | 1.2% |
| YTD | 109 114 | -5.7% | 33.4% | -2.1 | 589 286 560 | 21.8% | 46.1% | 1.7 | 0.1% |
| MAT | 631 283 | 3.3% | 32.6% | -4 | 2 978 469 687 | 15.5% | 42.7% | -3.2 | 16.0% |
| REDUXIN FORTE | |||||||||
| WoW | 3 502 | 11.8% | 8.9% | 0.1 | 15 542 319 | 10.2% | 10.4% | 0.1 | 11.0% |
| MoM | 14 156 | 9.0% | 9.1% | 0.7 | 63 823 923 | 12.0% | 10.5% | 1.2 | 1.2% |
| YTD | 28 657 | 10.9% | 8.8% | 0.9 | 127 568 794 | 34.4% | 10.0% | 1.3 | 0.1% |
| MAT | 168 841 | 33.7% | 8.7% | 1.2 | 686 163 925 | 43.6% | 9.8% | 1.3 | 16.0% |
| SALVISAR | |||||||||
| WoW | 9 493 | 21.6% | 1.2% | 0.2 | 3 708 708 | 25.4% | 1.1% | 0.2 | 4.5% |
| MoM | 35 330 | 4.5% | 1.1% | 0.1 | 13 170 717 | 12.2% | 1.0% | 0.1 | -3.3% |
| YTD | 73 246 | -24.8% | 1.1% | -0.5 | 26 507 577 | -15.5% | 0.9% | -0.5 | 12.3% |
| MAT | 474 303 | -23.6% | 1.2% | -0.4 | 158 872 085 | -24.6% | 1.0% | -0.4 | 6.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 59 434 | 29.5% | 11.1% | 2.4 | 133 432 644 | 62.4% | 9.6% | 2.3 | 1.2% |
| BRAINMAX | 8 717 | 86.4% | 100.0% | 0 | 31 397 995 | 98.6% | 100.0% | 0 | 86.4% |
| GOLDLINE PLUS | 143 094 | 6.3% | 43.8% | 2.5 | 462 617 322 | 14.3% | 36.2% | -0.9 | 0.1% |
| MIGRENIUM | 108 106 | 1.7% | 0.5% | -0.1 | 29 726 573 | 55.1% | 0.6% | 0.1 | 25.4% |
| MODELAX-N | 264 637 | 61.2% | 21.7% | 4.9 | 106 675 534 | 101.9% | 13.2% | 3.4 | 25.2% |
| REDUXIN CAPS | 109 114 | -5.7% | 33.4% | -2.1 | 589 286 560 | 21.8% | 46.1% | 1.7 | 0.1% |
| REDUXIN FORTE | 28 657 | 10.9% | 8.8% | 0.9 | 127 568 794 | 34.4% | 10.0% | 1.3 | 0.1% |
| SALVISAR | 73 246 | -24.8% | 1.1% | -0.5 | 26 507 577 | -15.5% | 0.9% | -0.5 | 12.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 354 373 | 34.9% | 9.5% | 1.8 | 708 092 095 | 46.7% | 8.1% | 1.5 | 9.0% |
| BRAINMAX | 50 691 | 241.0% | 100.0% | NA | 176 587 736 | 263.5% | 100.0% | NA | NA |
| GOLDLINE PLUS | 877 478 | 23.0% | 45.3% | 2.6 | 2 749 736 439 | 31.8% | 39.4% | 2.2 | 16.0% |
| MIGRENIUM | 643 348 | 9.5% | 0.6% | 0 | 133 220 302 | 26.4% | 0.5% | 0 | 12.1% |
| MODELAX-N | 1 268 406 | 141.3% | 19.5% | 9.7 | 436 640 808 | 149.1% | 11.0% | 5.5 | 21.2% |
| REDUXIN CAPS | 631 283 | 3.3% | 32.6% | -4 | 2 978 469 687 | 15.5% | 42.7% | -3.2 | 16.0% |
| REDUXIN FORTE | 168 841 | 33.7% | 8.7% | 1.2 | 686 163 925 | 43.6% | 9.8% | 1.3 | 16.0% |
| SALVISAR | 474 303 | -23.6% | 1.2% | -0.4 | 158 872 085 | -24.6% | 1.0% | -0.4 | 6.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 734 | 15.2% | 11.0% | -0.5 | 17 407 054 | 14.1% | 9.4% | -0.7 | 20.9% |
| BRAINMAX | 1 112 | 23.6% | 100.0% | 0 | 4 172 720 | 28.6% | 100.0% | 0 | 23.6% |
| GOLDLINE PLUS | 18 079 | 20.8% | 46.1% | 3.7 | 58 292 020 | 23.7% | 39.1% | 4.7 | 11.0% |
| MIGRENIUM | 12 244 | 5.5% | 0.6% | 0 | 3 581 724 | 7.8% | 0.7% | 0 | 4.0% |
| MODELAX-N | 35 540 | 17.1% | 25.4% | 2.3 | 14 725 034 | 17.6% | 15.9% | 1.6 | 6.4% |
| REDUXIN CAPS | 12 257 | 4.9% | 31.3% | -1.8 | 63 619 964 | -0.4% | 42.6% | -4 | 11.0% |
| REDUXIN FORTE | 3 502 | 11.8% | 8.9% | 0.1 | 15 542 319 | 10.2% | 10.4% | 0.1 | 11.0% |
| SALVISAR | 9 493 | 21.6% | 1.2% | 0.2 | 3 708 708 | 25.4% | 1.1% | 0.2 | 4.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 29 171 | 8.3% | 11.0% | -0.1 | 65 772 614 | 9.3% | 9.5% | -0.1 | 9.6% |
| BRAINMAX | 3 949 | -7.8% | 100.0% | 0 | 14 394 547 | -5.2% | 100.0% | 0 | -7.8% |
| GOLDLINE PLUS | 68 306 | 1.9% | 43.8% | 0.3 | 217 517 575 | -1.1% | 35.9% | -0.2 | 1.2% |
| MIGRENIUM | 53 054 | 6.6% | 0.6% | 0.1 | 15 088 199 | 15.2% | 0.7% | 0.1 | -6.1% |
| MODELAX-N | 129 731 | 8.5% | 23.0% | 2.9 | 53 054 568 | 12.2% | 14.2% | 2.2 | -5.0% |
| REDUXIN CAPS | 51 307 | -2.3% | 32.9% | -1.2 | 277 156 731 | -2.7% | 45.7% | -1 | 1.2% |
| REDUXIN FORTE | 14 156 | 9.0% | 9.1% | 0.7 | 63 823 923 | 12.0% | 10.5% | 1.2 | 1.2% |
| SALVISAR | 35 330 | 4.5% | 1.1% | 0.1 | 13 170 717 | 12.2% | 1.0% | 0.1 | -3.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs